Semax 10mg
99.1% HPLC PurityA synthetic ACTH fragment analogue studied in cognitive and neuroprotection research.

SKU: PW-025
Research-grade DSIP 10mg lyophilised powder. COA verified. Delta Sleep-Inducing Peptide, an endogenous nonapeptide studied in sleep-regulation and neuroendocrine research.
Read the full description ↓✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Dispatched next business day (orders before 11PM AEST)
A synthetic ACTH fragment analogue studied in cognitive and neuroprotection research.
Purity independently verified at a leading Australian university via HPLC & mass spectrometry.
Delta Sleep-Inducing Peptide (DSIP) is an endogenous nonapeptide first isolated in 1974 from the cerebral venous blood of rabbits during induced slow-wave sleep. Supplied as a lyophilised powder with full Certificate of Analysis (COA) documentation.
Our DSIP is sourced from GMP-certified manufacturing facilities with full chain-of-custody documentation maintained from synthesis to our Australian labs. Every batch undergoes independent third-party HPLC testing, mass spectrometry identity confirmation, LAL endotoxin assay (<1.0 EU/mg), and sterility screening before dispatch.
Research has explored DSIP's interaction with sleep-regulatory and neuroendocrine pathways, including EEG delta-wave activity in animal models and hypothalamic-pituitary-adrenal (HPA) axis signalling. The literature remains mixed: DSIP is structurally unrelated to the sedative-hypnotic drug classes, no specific receptor has been definitively characterised, and findings across studies have been inconsistent. Strictly for in-vitro laboratory research only.
Also searched as: Delta Sleep Inducing Peptide, DSIP peptide, delta sleep peptide
DSIP appears in the literature and in supplier catalogues under its full name, Delta Sleep-Inducing Peptide, as well as the shortened delta sleep peptide. Each refers to the same nonapeptide research compound: DSIP, the product on this page.
DSIP (Delta Sleep-Inducing Peptide) is an endogenous nonapeptide studied in preclinical research for its interaction with sleep-regulatory and neuroendocrine pathways, including EEG delta-wave activity and HPA axis signalling. Findings across the literature have been inconsistent and no specific receptor has been definitively characterised. All use is strictly for in-vitro laboratory research only.
DSIP is a nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE), molecular formula C₃₅H₄₈N₁₀O₁₅ and a molecular weight of approximately 848.8 Da. Its CAS number is 62568-57-4.
Store lyophilised at −20°C for long-term stability, protected from light and moisture. Once reconstituted with bacteriostatic water, store at 2–8°C and use within 4 weeks. Avoid repeated freeze-thaw cycles.
Add bacteriostatic water (BAC water) slowly to the vial at a 1–2mL volume. Gently swirl; do not shake. Allow the lyophilised powder to dissolve completely before use in research protocols.
Yes. Every batch of DSIP ships with a downloadable COA including HPLC purity percentage, mass spectrometry identity confirmation, sterility results, and LAL endotoxin assay data.
Yes. DSIP is legal to purchase in Australia for legitimate in-vitro laboratory and research purposes. It is not approved for human consumption or therapeutic use.
DSIP 10mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
No questions yet — be the first to ask about this product.
A synthetic analogue of the immune peptide tuftsin, studied in anxiolytic and nootropic research.
A triple GLP-1, GIP and glucagon receptor agonist, supplied as a 10mg lyophilised vial.
Recent peer-reviewed studies from PubMed related to DSIP. Provided for research context — not medical advice.
Delta sleep-inducing peptide
Pollard BJ, Pomfrett CJ · European journal of anaesthesiology · 2001
PMID: 11437870
Delta-sleep-inducing peptide (DSIP): a review
Graf MV, Kastin AJ · Neuroscience and biobehavioral reviews · 1984
PMID: 6145137
Delta sleep-inducing peptide (DSIP): a still unresolved riddle
Kovalzon VM, Strekalova TV · Journal of neurochemistry · 2006
PMID: 16539679
Delta-sleep-inducing peptide (DSIP): an update
Graf MV, Kastin AJ · Peptides · 1986
PMID: 3550726
Source: U.S. National Library of Medicine (PubMed). Citations are fetched live and cached; inclusion does not imply endorsement of any therapeutic use.